XCANM Stock Overview
Xtrackers MSCI Canada ESG Screened UCITS ETF is an exchange-traded fund launched by Deutsche Asset Management S.A.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Xtrackers MSCI Canada ESG Screened UCITS ETF Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$69.87 |
52 Week High | US$0 |
52 Week Low | US$0 |
Beta | 0 |
1 Month Change | -3.07% |
3 Month Change | 0.92% |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 10.73% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
XCANM | GB Capital Markets | GB Market | |
---|---|---|---|
7D | -0.05% | 1.2% | 1.1% |
1Y | n/a | 6.5% | 1.9% |
Return vs Industry: Insufficient data to determine how XCANM performed against the UK Capital Markets industry.
Return vs Market: Insufficient data to determine how XCANM performed against the UK Market.
Price Volatility
XCANM volatility | |
---|---|
XCANM Average Weekly Movement | 1.6% |
Capital Markets Industry Average Movement | 4.3% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.5% |
10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: XCANM has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine XCANM's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2010 | n/a | n/a | etf.dws.com/LUX/ENG/ETF/LU0476289540/-/MSCI-Canada-Index-UCITS-ETF |
Xtrackers MSCI Canada ESG Screened UCITS ETF is an exchange-traded fund launched by Deutsche Asset Management S.A. The fund is co-managed by Deutsche Asset Management Investment GmbH and Deutsche Asset Management (UK) Limited. It invests in the public equity markets of Canada.
Xtrackers MSCI Canada ESG Screened UCITS ETF Fundamentals Summary
XCANM fundamental statistics | |
---|---|
Market cap | €322.28m |
Earnings (TTM) | €0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs XCANM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
XCANM income statement (TTM) | |
---|---|
Revenue | €0 |
Cost of Revenue | €0 |
Gross Profit | €0 |
Other Expenses | €0 |
Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did XCANM perform over the long term?
See historical performance and comparison